z-logo
open-access-imgOpen Access
All MAPT out?: Well-travelled pathways into neurodegeneration
Author(s) -
Selina Wray,
John Hardy
Publication year - 2010
Publication title -
the biochemist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 7
eISSN - 1740-1194
pISSN - 0954-982X
DOI - 10.1042/bio03202014
Subject(s) - neurodegeneration , mendelian inheritance , disease , biology , tau protein , genetics , gene , neuroscience , alzheimer's disease , medicine , pathology
Neurodegenerative disorders are characterized pathologically by insoluble protein aggregates in the neurons of affected brain regions. A common theme in neurodegenerative disease which has emerged is that mutations in the genes encoding the abnormally deposited protein cause autosomal-dominant inherited forms of disease. More recently, it has become apparent that common genetic variance at the same loci that cause Mendelian disease predispose risk to sporadic disease, generally by altering the expression levels of wild-type protein. The microtubule-associated protein tau (MAPT) is a classical example of this principle, and in this article, we discuss the biology and genetics of MAPT in disease, and compare and contrast MAPT with other loci implicated in neurodegeneration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom